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ABSTRACT
This is the annual report for the first year of this grant. The goal of this grant is to study 26 women undergoing chemotherapy for breast cancer, assessing their fatigue levels before, during and after treatment, and correlating fatigue with CMV serostatus, the immune response to CMV, and cytokine levels. During this first year we completed the technical arrangements for the study and enrolled the first 9 patients. 4 are CMV seronegative, and 5 are seropositive. Fatigue survey data, serum, PBMC and urine have been collected and stored. We will collect four time points on each patientt. One patients has completed the study, the others are in progress. During this year we performed quality control tests on PBMC preservation, and established our initial panel of antibodies to be used for intracellular cytokine staining and FACS analysis. Patient recruitment has been proceeding at an acceptable pace and no problems are anticipated in recuiriting the full study cohort within the allotted time. Furthermore, our patients are fairly equally distributed between CMV serpositives and seronegatives, which gives best statistical power for the study and optimizes our likelihood of recruiting the full patient cohort. 
INTRODUCTION
This is the first annual report for this award, which is for a small clinical study of breast cancer treatment related fatigue, and specifically the role of CMV reactivation in causing fatigue. Here we report on our initial recruitment of subjects for this study.
BODY
Herein we list the statement of work from the grant application (in italics), and describe progress.
1. Obtain IRB approval for the study including design of study flyer (pre award, month -6-0 
